A new study on HMGB1’s Box A domain shows it can create DNA gaps, reversing age-related damage in non-human primates with up to 40% proteomic improvement, highlighting potential gene therapy for...
The FDA’s updated guidelines on cellular reprogramming, highlighted by Life Biosciences’ ER-100 trial for eye conditions, signal a pivotal shift that could accelerate anti-aging therapies,...
Exploring the latest breakthroughs in partial reprogramming using OSKM factors for anti-aging, with insights from mouse studies and early clinical trials for eye diseases. Recent studies show partial ...
The FDA has greenlit the first human trial of ER-100, a partial epigenetic reprogramming therapy targeting age-related eye diseases, marking a pivotal step in anti-aging and regenerative medicine. A l...
Eli Lilly’s AI collaborations via TuneLab cut preclinical timelines by up to 30% and reduce attrition rates, democratizing drug discovery for smaller firms with enhanced data privacy. Eli Lilly&...
A June 2024 study reveals turmeric oil-chitosan-PVA nanocomposites effectively combat Pythium myriotylum in ginger crops, aligning with EU fungicide regulations and BioShield India’s field trial...
Exploring the transformative role of extracellular vesicles in diagnostics, therapy, and regenerative medicine, with insights from leading researchers and recent studies. Extracellular vesicles are em...
Exosome therapy is revolutionizing regenerative medicine, offering new hope for treating heart disease, neurodegenerative disorders, and tissue damage through cutting-edge research and clinical trials...
